老年单发小肝癌:腹腔镜肝切除对比射频消融的多中心倾向评分匹配研究
该多中心倾向评分匹配研究比较了年龄≥70岁、单发≤3cm肝细胞癌患者接受腹腔镜肝切除或射频消融的围术期与长期结局。匹配后每组102例,腹腔镜肝切除虽并发症更多、住院更长,但总生存和无病生存均优于射频消融,且射频消融是预后更差的独立危险因素。
要点
- 腹腔镜肝切除组5年总生存65.7% vs 射频消融50.0%,无病生存40.2% vs 34.3%。
- 射频消融是总生存(HR 2.18)和无病生存(HR 2.42)更差的独立危险因素。
- 肝功能好、体能状态佳且无门脉高压的老年患者可优先考虑腹腔镜肝切除。
核心结论
- 在经选择的老年单发小肝癌患者中,腹腔镜肝切除较射频消融提供更优的长期总生存和无病生存。
- 腹腔镜肝切除应作为手术条件好的老年患者的一线选择,尤其体能状态好、肝功能佳者。
- 射频消融可作为高手术风险或肿瘤≤2cm患者的有效替代方案。
研究设计与样本
- 多中心倾向评分匹配研究,纳入8个三级中心年龄≥70岁、单发≤3cm肝细胞癌患者。
- 比较腹腔镜肝切除与射频消融,倾向评分匹配按1:1平衡基线特征。
- 匹配后每组各102例,比较围术期结局、总生存和无病生存,Cox回归分析独立预后因素。
主要发现
- 腹腔镜肝切除手术时间更长、出血更多、住院更久、总体并发症更多(均P<.05),但90天死亡率无差异。
- 腹腔镜肝切除总生存更优(中位未达到 vs 67.5个月,5年65.7% vs 50.0%,P=.005)。
- 腹腔镜肝切除无病生存更优(中位36.8 vs 21.3个月,5年40.2% vs 34.3%,P<.001)。
- 多因素分析显示射频消融是总生存更差的独立危险因素(HR 2.18,P=.011)和无病生存更差的独立危险因素(HR 2.42,P=.001)。
- 亚组分析显示腹腔镜肝切除的生存获益在无门脉高压、ASA I-II、Child-Pugh A、MELD≤9、血小板>100×10^9/L、白蛋白>35g/L、肿瘤>2cm、病灶未接触Glisson蒂及无肝硬化患者中更明显。
临床怎么用
- 对手术条件好的老年单发小肝癌患者,尤其体能状态好、肝功能佳者,可优先考虑腹腔镜肝切除。
- 对高手术风险或肿瘤≤2cm的患者,射频消融可作为有效替代,其肿瘤学结局相当且并发症更少、恢复更快。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal local treatment for solitary small hepatocellular carcinoma in elderly patients remains unclear. This multicenter propensity score-matched study compared perioperative and long-term outcomes between laparoscopic liver resection and radiofrequency ablation in this population. METHODS: Elderly patients (defined as age ≥70 years) with solitary hepatocellular carcinoma ≤3 cm who underwent laparoscopic liver resection or radiofrequency ablation at 8 tertiary centers were included. Propensity score matching (1:1) balanced baseline characteristics. Perioperative outcomes, overall survival, and disease-free survival were compared. Independent prognostic factors were identified by Cox regression. RESULTS: After propensity score matching, 102 patients were included in each group. Laparoscopic liver resection was associated with longer operative time, higher blood loss, longer hospital stay, and more overall complications (all P < .05), but 90-day mortality did not differ. Laparoscopic liver resection achieved superior overall survival (median, not reached versus 67.5 months, 5-year: 65.7% vs 50.0%; P = .005) and disease-free survival (median, 36.8 vs 21.3 months, 5-year: 40.2% vs 34.3%; P < .001). On multivariate analysis, radiofrequency ablation was an independent risk factor for worse overall survival (hazard ratio, 2.18; P = .011) and disease-free survival (hazard ratio, 2.42; P = .001). Subgroup analyses showed that the survival benefit of laparoscopic liver resection was pronounced in patients with no portal hypertension, American Society of Anesthesiologists physical status I-II, Child-Pugh A, model for end-stage liver disease ≤9, platelet >100 × 109/L, albumin >35 g/L, tumor >2 cm, no lesion contact with Glissonian pedicles, and the absence of cirrhosis. CONCLUSION: In selected elderly patients with solitary small hepatocellular carcinoma, laparoscopic liver resection provides superior long-term overall survival and disease-free survival compared with radiofrequency ablation, despite a higher rate of specific complications including posthepatectomy liver failure and ascites and a numerically higher 90-day mortality. Laparoscopic liver resection should be considered first line in surgically fit elderly patients, especially those with good performance status and favorable liver function. Radiofrequency ablation may be considered a valid alternative in patients with high surgical risks or tumors ≤2 cm, as it achieved comparable oncologic outcomes with significantly lower morbidity and faster recovery.
引用
- Yang S, Feng J, Zou M, et al. Laparoscopic liver resection versus radiofrequency ablation for solitary small hepatocellular carcinoma in elderly patients: A multicenter propensity score-matched study. Surgery. 2026. PMID: 42686461. doi:10.1016/j.surg.2026.110481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。